Eduovisual
Patient Safety & Systems-Based Practice
Catheter-associated UTI prevention bundle
— NHSN surveillance criteria require ≥1 symptom (fever >38°C, suprapubic tenderness, costovertebral angle pain/tenderness, urinary urgency/frequency/dysuria after removal) plus urine culture ≥10⁵ CFU/mL of no more than 2 organisms.
— Asymptomatic bacteriuria (ASB) in a catheterized patient is not CAUTI and should not be treated except in pregnancy or pre-urologic procedure.
— Most common healthcare-associated infection in the US; ~75% of inpatient UTIs are catheter-associated.
— Each catheter-day increases bacteriuria risk by 3–7%; by day 30, virtually 100% of catheterized patients are bacteriuric.
— CMS classifies CAUTI as a hospital-acquired condition (HAC) — no incremental reimbursement, publicly reported, tied to value-based purchasing penalties.
— New fever, leukocytosis, delirium, hypotension, or rigors in a catheterized patient with no alternative source.
— Suprapubic pain, flank pain, or hematuria.
— Post-removal dysuria/urgency within 48 h.
— Sepsis of unclear source in long-term care residents with chronic catheters.
— Cloudy or malodorous urine alone is not an indication to culture or treat.
— Pyuria is universal with catheters and does not distinguish ASB from CAUTI.
Board pearl: Step 3 stems often present a catheterized patient with cloudy urine and no systemic symptoms — the correct answer is remove the catheter if no longer indicated, do not culture, do not start antibiotics. Treating ASB is a wrong-answer trap that drives resistance, C. difficile, and HAC penalties. Always confirm symptoms attributable to the urinary tract before sending a culture in a catheterized patient.
— Fever ≥38°C without another source, new suprapubic or flank/CVA tenderness, rigors, or new-onset delirium in elderly.
— Hematuria (gross or microscopic) developing during catheterization.
— Acute hemodynamic deterioration → urosepsis (hypotension, tachycardia, end-organ dysfunction).
— Dysuria, urgency, frequency, or suprapubic pain within 48 hours of catheter removal — counts as CAUTI per NHSN.
— Altered mental status, functional decline, anorexia, or falls — but only attribute to UTI after ruling out dehydration, medications, metabolic derangements, and other infections.
— Key distinction: Confusion + bacteriuria ≠ UTI. Step 3 rewards withholding antibiotics in afebrile, hemodynamically stable elderly patients with delirium and isolated bacteriuria; pursue alternative workup first.
— Catheter indication and duration: Was placement appropriate (acute retention, accurate I/O in critically ill, perioperative for select surgeries, sacral/perineal wound healing in incontinent patient, end-of-life comfort, prolonged immobilization)? Convenience and incontinence alone are not valid indications.
— Date of insertion, who placed it, sterile technique documented?
— Prior catheterizations, prior MDR organisms (ESBL, CRE, Pseudomonas, VRE).
— Recent antibiotics (within 90 days) → resistance risk.
— Structural abnormalities: BPH, neurogenic bladder, stones, recent GU instrumentation.
— Immunosuppression, diabetes, pregnancy, transplant.
— Long-term care residence, recent hospitalization, hemodialysis access — escalate empiric coverage.
Step 3 management: On admission of any catheterized patient, the first cognitive step is to interrogate the indication daily using a nurse-driven removal protocol. Document the indication in the EHR; if none of the accepted criteria apply, the catheter must come out. This single behavior is the highest-impact element of the CAUTI prevention bundle and is heavily tested.
— Fever >38°C, tachycardia, hypotension (SBP <90 or MAP <65), tachypnea, hypoxia → screen for sepsis/septic shock using qSOFA or SIRS at bedside.
— Hypothermia in elderly or immunocompromised can also signal severe infection.
— Suprapubic palpation: tenderness, distended bladder (suggests obstruction or kinked catheter).
— CVA tenderness: pyelonephritis component.
— Inspect catheter: dependent drainage? bag below bladder? kinking? encrustation? leakage around catheter (suggests obstruction or bladder spasm)?
— Meatal inspection: purulence, erythema, trauma; in men assess for epididymitis, prostate tenderness on gentle DRE (avoid vigorous prostate massage in suspected prostatitis — risk of bacteremia).
— Perineal/scrotal skin breakdown if long-term catheter.
— Lungs (HCAP/VAP), abdomen (C. difficile, cholangitis), lines (CLABSI), surgical sites, skin (cellulitis, pressure injuries), joints.
— Confirm balloon volume, tubing not under tension, drainage bag closed system intact, no dependent loops.
— CCS pearl: On the CCS case, after confirming catheter-related sepsis suspicion, order "Vital signs q1h," "Urine culture from freshly placed catheter (not from old catheter)," "Blood cultures × 2," and replace or remove the catheter before starting antibiotics — culture from a biofilm-laden indwelling catheter is unreliable.
— Stable, low-grade fever → ward, targeted workup.
— SIRS + lactate >2 → step-down or ICU; initiate sepsis bundle (lactate, cultures before antibiotics, 30 mL/kg crystalloid if hypotensive or lactate ≥4, broad-spectrum antibiotics within 1 hour, vasopressors for MAP <65 after fluids).
Board pearl: Sampling urine from an old indwelling catheter is a classic wrong answer — biofilm colonizers contaminate the specimen. Always remove or exchange the catheter and culture from the new one (or from a midstream void if no longer catheter-dependent).
— Pyuria (WBC >10/hpf) is present in >90% of catheterized patients regardless of infection — poor specificity.
— Absence of pyuria has high NPV — argues strongly against CAUTI.
— Nitrites: positive suggests Enterobacterales (E. coli, Klebsiella, Proteus); negative does not exclude Enterococcus, Pseudomonas, Staphylococcus, or Candida.
— Leukocyte esterase: same caveats.
— Obtain only when symptoms are present. Routine surveillance cultures drive overtreatment.
— Sample from a freshly placed catheter or via the sampling port after disinfection — never from the drainage bag.
— Threshold: ≥10⁵ CFU/mL with ≤2 organisms; ≥10³ CFU/mL acceptable in symptomatic patients per IDSA.
— Polymicrobial growth or Candida often represents colonization.
— Two sets before antibiotics if febrile, septic, or immunocompromised. Bacteremia occurs in ~10% of CAUTI; gram-negative bacteremia carries higher mortality.
— CBC with differential (leukocytosis, bandemia, or leukopenia).
— BMP (AKI from sepsis or obstruction), lactate (sepsis severity), procalcitonin (adjunct, not a substitute for clinical judgment).
— LFTs if cholangitis on differential; CK if rhabdomyolysis from prolonged immobilization.
— Post-void residual to confirm retention before reinserting a catheter that may not be needed.
Key distinction: Asymptomatic bacteriuria + pyuria in a catheterized patient = do not treat (except pregnancy or pre-urologic procedure with mucosal trauma). Symptomatic CAUTI = treat. The exam tests this discrimination relentlessly because inappropriate treatment of ASB is one of the most common antimicrobial stewardship failures and a publicly reported quality metric.
— Renal/bladder ultrasound: first-line if obstruction, hydronephrosis, or perinephric abscess suspected; preferred in pregnancy, AKI, and to avoid contrast.
— CT abdomen/pelvis with contrast: gold standard for emphysematous pyelonephritis, renal/perinephric abscess, obstructing stone with infection, and to evaluate non-responders after 48–72 h of appropriate antibiotics.
— Non-contrast CT (stone protocol) if obstruction is the leading concern and renal function limits contrast.
— Persistent fever or bacteremia >72 h on appropriate therapy.
— Suspected obstruction (anuria, flank pain, rising creatinine).
— Diabetes with severe pyelonephritis → rule out emphysematous pyelonephritis (urologic/IR emergency).
— Recurrent CAUTI in same patient.
— Cystoscopy: not acute; consider for recurrent infection, hematuria, or suspected foreign body/stone.
— Urodynamics: for neurogenic bladder evaluation in long-term catheter candidates considering alternatives (intermittent catheterization, suprapubic).
— Prostate ultrasound or MRI: if prostatic abscess suspected (men with prolonged fever despite therapy).
— Repeat cultures only if no clinical improvement at 48–72 h or to confirm clearance in bacteremia.
— Susceptibility testing guides de-escalation — a stewardship priority.
— Obstructing stone with infection = urologic emergency → percutaneous nephrostomy or ureteral stent plus antibiotics. Antibiotics alone fail without drainage.
CCS pearl: In a CCS case of obstructing infected stone, the high-yield orders are: IV fluids, blood and urine cultures, broad-spectrum antibiotics (piperacillin-tazobactam or ceftriaxone), urology consult for emergent decompression, and ICU transfer if septic. Delaying decompression while waiting for antibiotics to work is the wrong-answer trap and a real-world mortality driver.
— Apply HOUDINI criteria daily: Hematuria (gross), Obstruction, Urology surgery, Decubitus ulcer (stage 3–4 with incontinence), Input/output critical, Not for resuscitation/comfort care, Immobility (specific clinical reason).
— If none apply → remove. This is the single most evidence-based CAUTI prevention intervention.
— Uncomplicated symptomatic CAUTI (afebrile or low-grade fever, no sepsis, no obstruction): oral antibiotics, outpatient possible if reliable follow-up.
— Complicated CAUTI (fever ≥38.5°C, sepsis, bacteremia, obstruction, immunocompromise, pregnancy, transplant, recent GU surgery): IV antibiotics, admission, imaging.
— Local antibiogram.
— Prior cultures (within 90 days) and resistance history.
— Healthcare exposure (hospital, LTC, hemodialysis).
— Severity (sepsis → broadest spectrum; mild → narrower).
— Allergies and renal function.
— Replace the catheter if it has been in place >2 weeks and is still needed — biofilm harbors persistent organisms.
— Relieve obstruction emergently.
— Drain abscesses.
— De-escalate at 48–72 h based on cultures.
— Total duration: 7 days for prompt responders, 10–14 days for delayed response or bacteremia, 5 days for women <65 with rapid resolution after catheter removal (levofloxacin data).
Step 3 management: The exam expects a deliberate sequence: assess catheter necessity → remove if possible → culture properly → empirically treat based on severity and risk → de-escalate → set defined stop date. Documentation of indication and a planned removal date in the EHR is the systems-level answer when the question stem invokes a "quality improvement initiative" or "Plan-Do-Study-Act cycle" framing.
— Ceftriaxone 1 g IV q24h (inpatient) or cefpodoxime/cefuroxime PO (outpatient).
— Alternative: TMP-SMX DS BID if local E. coli resistance <20% and patient not recently on it.
— Nitrofurantoin and fosfomycin: avoid — inadequate tissue penetration for pyelonephritis or complicated UTI; reserved for uncomplicated cystitis only.
— Piperacillin-tazobactam 4.5 g IV q6–8h (extended infusion preferred) or cefepime 2 g IV q8h — cover Pseudomonas and most Enterobacterales.
— Add vancomycin if prior MRSA, ICU, or gram-positive cocci on Gram stain.
— Meropenem 1 g IV q8h if ESBL risk (prior ESBL, recent broad-spectrum exposure, travel to high-prevalence region).
— Ceftolozane-tazobactam or ceftazidime-avibactam for documented MDR Pseudomonas or CRE — ID consult.
— E. coli, Klebsiella (susceptible): ceftriaxone, ciprofloxacin, TMP-SMX.
— Pseudomonas: cefepime, piperacillin-tazobactam, ciprofloxacin (oral step-down).
— Enterococcus faecalis: ampicillin (preferred), amoxicillin PO step-down.
— Enterococcus faecium (often VRE): linezolid or daptomycin (note daptomycin inactivated by surfactant — but achieves urine levels; linezolid preferred for bacteremia).
— Candida: treat only if symptomatic — remove/exchange catheter; fluconazole 200–400 mg daily × 14 days if symptomatic or neutropenic.
— 7 days if prompt response.
— 10–14 days for delayed response, bacteremia, or complicated course.
— 5 days levofloxacin acceptable in select rapid responders.
Board pearl: Fluoroquinolones now carry FDA boxed warnings (tendinopathy, aortic dissection, neuropathy, dysglycemia, QT prolongation) — reserve for cases without alternatives. On Step 3, choosing ciprofloxacin for uncomplicated cystitis when nitrofurantoin or TMP-SMX would suffice is the wrong answer.
— 1. Avoid unnecessary catheterization. Use bladder scanners, condom catheters in cooperative men, intermittent straight catheterization, scheduled toileting, and absorbent products. Convenience and routine urine output monitoring in non-critical patients are not indications.
— 2. Aseptic insertion. Trained personnel only, hand hygiene, sterile gloves/drape/equipment, sterile lubricant, appropriate catheter size (smallest that drains adequately, typically 14–16 Fr).
— 3. Maintain a closed drainage system. Do not disconnect tubing; if break occurs, replace catheter and collection system aseptically.
— 4. Proper positioning. Drainage bag below bladder at all times, never on the floor, no dependent loops. Secure catheter to thigh to prevent traction/urethral trauma.
— 5. Daily review of necessity. Nurse-driven removal protocols are the highest-evidence systems intervention; reduce catheter-days by 30–50%.
— 6. Routine perineal care with soap and water — no routine antiseptic meatal cleaning, no antimicrobial-coated catheters as routine, no bladder irrigation, no prophylactic antibiotics at insertion or removal.
— 7. Hand hygiene before and after catheter manipulation; gloves for emptying bag using a clean, individual container.
— External "PureWick"-style female condom catheters and male condom catheters reduce CAUTI rates significantly in appropriate candidates.
— Intermittent catheterization preferred for neurogenic bladder long-term.
— Suprapubic catheter for chronic need (urethral stricture, prolonged use) — lower symptomatic UTI rates than urethral.
— Track catheter-days, CAUTI rate per 1,000 catheter-days, and standardized infection ratio (SIR).
— Use PDSA cycles, audit-feedback, and EHR hard stops requiring indication documentation.
CCS pearl: When a CCS case offers "insert Foley catheter" as a low-effort order for an ambulatory ward patient without a clear indication, decline it — choosing it drops your patient-safety score. Order bladder scan first and bedside commode/intermittent catheterization if retention is confirmed.
— Highest absolute risk for CAUTI and for inappropriate treatment of asymptomatic bacteriuria.
— Delirium alone in a stable, afebrile elderly catheterized patient should not trigger antibiotics — first evaluate hydration, medications (anticholinergics, opioids, benzodiazepines), pain, constipation, hypoxia, and metabolic derangements.
— Polypharmacy: avoid nitrofurantoin if CrCl <30 mL/min (inadequate urinary levels, peripheral neuropathy risk); avoid fluoroquinolones (tendinopathy, QT, delirium, hypoglycemia with sulfonylureas, aortic risk).
— Falls risk increases with catheter tubing tethering and with antibiotic-induced C. difficile diarrhea.
— Skin: monitor for meatal pressure injuries; reposition catheter and use securement device.
— Dose-adjust: cefepime (neurotoxicity in CKD — myoclonus, encephalopathy, nonconvulsive status), piperacillin-tazobactam, levofloxacin, TMP-SMX (hyperkalemia, AKI), aminoglycosides (avoid if possible).
— Key distinction: Cefepime neurotoxicity is a classic Step 3 vignette — confused elderly CKD patient on cefepime → check renal dosing, consider EEG, switch agent. Often missed because providers attribute to "ICU delirium."
— Vancomycin: AUC-guided dosing preferred; monitor trough/AUC and renal function.
— Contrast imaging: weigh risk; ultrasound first when feasible.
— Avoid ceftriaxone in neonates with hyperbilirubinemia; in adults with biliary sludging risk, consider alternatives in prolonged courses.
— TMP-SMX: hepatotoxicity, monitor LFTs.
— Adjust metronidazole and linezolid in severe hepatic dysfunction.
— High burden of MDR organisms; review prior cultures before empiric choice.
— Avoid chronic catheters when possible; consider scheduled exchange every 2–4 weeks if required, though evidence for fixed interval is limited.
Board pearl: Treating ASB in elderly nursing home residents does not reduce mortality, falls, or functional decline, but does increase C. difficile, MDR colonization, and adverse drug events. The right answer on Step 3 is observation + supportive care unless symptoms localize to the urinary tract.
— Asymptomatic bacteriuria must be screened and treated (one of the few ASB-treat indications) — untreated ASB → 20–30% pyelonephritis, preterm labor, low birth weight.
— Avoid catheters when possible; if needed peripartum, remove ASAP postpartum.
— Safe antibiotics: cephalexin, cefpodoxime, ceftriaxone, amoxicillin-clavulanate.
— Avoid: fluoroquinolones (cartilage), TMP-SMX (1st trimester — neural tube defects; near term — kernicterus), nitrofurantoin (near term — hemolysis; avoid 1st trimester per ACOG when alternatives exist), aminoglycosides (ototoxicity).
— Pyelonephritis in pregnancy → admit, IV ceftriaxone, monitor for ARDS and preterm labor.
— Catheter use limited; bag specimens unreliable — use straight catheterization or suprapubic aspiration for diagnosis.
— Empiric: ceftriaxone or cefepime; avoid fluoroquinolones except when no alternative.
— Always evaluate for VUR or anatomic abnormality after febrile UTI in young children (renal/bladder US; VCUG per AAP if atypical or recurrent).
— Neutropenia, transplant, chemotherapy: lower threshold to admit, broaden empiric coverage (antipseudomonal), and treat Candida even at lower colony counts.
— Renal transplant: always treat bacteriuria within first 1–3 months post-transplant; afterward, treat only if symptomatic per most centers.
— Spinal cord injury / neurogenic bladder: high baseline colonization; treat only symptomatic episodes (autonomic dysreflexia, fever, increased spasticity, new incontinence between catheterizations).
— Treat ASB before procedures expected to cause mucosal trauma (TURP, biopsy) — single dose or short course based on culture.
Step 3 management: Pregnant patient with positive urine culture and no symptoms → treat with 5–7 days of pregnancy-safe antibiotic, then test of cure 1–2 weeks later, then monthly urine cultures through pregnancy. This cadence is high-yield and frequently tested as a longitudinal management question.
— Urosepsis / septic shock: ~10% of CAUTI bacteremic; mortality 10–30% depending on host.
— Pyelonephritis: flank pain, fever, vomiting; risk of renal scarring with recurrent episodes.
— Renal or perinephric abscess: suspect if fever persists >72 h on appropriate therapy; CT diagnostic, drainage often required.
— Emphysematous pyelonephritis: diabetic patients, gas in renal parenchyma on CT, mortality 20%+, requires aggressive antibiotics ± percutaneous drainage or nephrectomy.
— Prostatitis / prostatic abscess (men): prolonged courses (4–6 weeks) of fluoroquinolone or TMP-SMX with prostate penetration; drainage for abscess.
— Epididymo-orchitis.
— Bacteremia and metastatic seeding (endocarditis, vertebral osteomyelitis, especially with Enterococcus and S. aureus).
— Urethral trauma, false passage, strictures (especially with traumatic insertion or large-bore catheters).
— Bladder spasms, leakage around catheter.
— Catheter encrustation, blockage, and bladder stone formation — especially with Proteus mirabilis (urease → struvite stones).
— Hematuria, clot retention.
— Meatal pressure injuries.
— C. difficile infection from broad-spectrum antibiotics — colectomy and death possible.
— Antibiotic-associated AKI (vancomycin, piperacillin-tazobactam combination shows increased AKI risk vs cefepime in some studies).
— MDR colonization driving future infections.
— Fluoroquinolone-associated tendon rupture, aortic dissection, neuropathy, dysglycemia, QT prolongation.
— Hospital-acquired condition (HAC) → CMS payment penalty.
— Increased length of stay (mean 1–4 days), $1,000–$5,000+ per case.
— Publicly reported on Hospital Compare; affects value-based purchasing.
Board pearl: In a male patient with CAUTI failing to defervesce on appropriate antibiotics after 72 h, think prostatic abscess — order transrectal ultrasound or MRI, consult urology for drainage, and extend therapy to 4–6 weeks. Missing this is a high-yield wrong-answer trap.
— Septic shock (vasopressor requirement after 30 mL/kg crystalloid).
— Lactate ≥4 mmol/L or persistent lactate >2 after resuscitation.
— Respiratory failure (ARDS more common in pregnancy-associated pyelonephritis).
— AKI requiring renal replacement therapy.
— Altered mental status requiring airway protection.
— Emphysematous pyelonephritis.
— Bacteremia with stable hemodynamics on early antibiotics.
— Significant comorbidities (advanced CKD, transplant, neutropenia).
— Complicated CAUTI requiring IV antibiotics, source control, or unable to tolerate oral.
— Pyelonephritis in pregnancy (all admit per ACOG).
— Failed outpatient therapy.
— Mild symptomatic CAUTI in stable, non-pregnant, non-immunocompromised patient with reliable follow-up and oral tolerance.
— Document 48–72 h follow-up plan and explicit return precautions (fever, vomiting, worsening pain).
— Urology: obstruction, abscess, recurrent CAUTI, suspected stricture, hematuria with clots, prostatic abscess, candidates for suprapubic catheter.
— Infectious Disease: MDR organisms (ESBL, CRE, MDR Pseudomonas, VRE), persistent bacteremia, transplant, complicated/atypical course.
— Interventional Radiology: percutaneous nephrostomy for obstructed infected kidney when retrograde stenting fails, abscess drainage.
— Palliative care: end-of-life patients where catheter is for comfort — reframe goals rather than escalate antibiotics.
CCS pearl: For an obstructed infected kidney, the sequence on CCS is: IV fluids → blood cultures → broad-spectrum antibiotics → urology consult for emergent decompression → ICU monitoring. Advancing the clock without ordering decompression results in deterioration and a scoring penalty. Source control beats antibiotic choice every time.
— Bacteriuria + pyuria without urinary or systemic symptoms attributable to UTI.
— Do not treat except pregnancy or pre-urologic mucosal procedure.
— Dysuria, urgency, frequency in healthy non-pregnant women; nitrofurantoin, TMP-SMX, fosfomycin first-line. Not applicable if catheterized.
— Flank pain, fever, CVA tenderness, often nausea/vomiting; treat with ceftriaxone or fluoroquinolone; admit if pregnant, septic, or unable to tolerate PO.
— Fever, perineal/pelvic pain, urinary symptoms, boggy tender prostate; treat 4–6 weeks with prostate-penetrating agents (fluoroquinolone or TMP-SMX).
— Unilateral scrotal pain and swelling; <35 yr think C. trachomatis/N. gonorrhoeae (ceftriaxone + doxycycline), >35 yr or insertive anal intercourse think enteric organisms.
— Obstructing stone + UTI = urologic emergency requiring decompression.
— Painless hematuria, especially in older smokers; persistent "UTI" despite treatment → cystoscopy.
— Chronic pelvic pain, frequency, sterile cultures; not infectious — diagnosis of exclusion.
— Bladder spasm, kinked tubing, encrustation causing pain/leakage without infection.
— Persistent fever despite appropriate antibiotics; CT diagnostic.
Key distinction: A catheterized patient with positive urine culture but no fever, no suprapubic/CVA tenderness, no hemodynamic change, and no leukocytosis attributable to UTI has ASB, not CAUTI. The exam will dangle a positive culture and pyuria in front of you — anchor on symptoms, not numbers. Treating ASB is consistently the wrong answer outside pregnancy and pre-urologic procedure.
— Fever, leukocytosis, new infiltrate, increased secretions; CXR and respiratory cultures.
— Fever with line in place >48 h, no other source; paired blood cultures from line and peripheral. Often more likely than CAUTI in ICU patients with both devices.
— Watery diarrhea, leukocytosis (sometimes massive), recent antibiotics; stool PCR/toxin EIA. Fever and leukocytosis without diarrhea = think other source.
— Inspect wounds; deep SSI may have minimal external findings.
— Sacral or heel ulcers in immobile catheterized patients can seed bacteremia.
— Cholecystitis, cholangitis, diverticulitis, abscess; abdominal exam, LFTs, imaging.
— Beta-lactams, sulfa, phenytoin; relative bradycardia, eosinophilia, otherwise well-appearing.
— Immobile catheterized patients are high-risk; low-grade fever can accompany.
— Particularly with Enterococcus or S. aureus bacteremia from a urinary source; obtain echocardiogram (TEE if high suspicion).
Board pearl: In a febrile ICU patient with both a Foley and a central line, do not anchor on bacteriuria. Bacteriuria is nearly universal by ICU day 5. Pursue a parallel workup — paired blood cultures, CXR, examine all lines/wounds, consider C. difficile, abdominal imaging if indicated. Removing or exchanging both devices is often part of the answer for unexplained sepsis in a catheterized, line-bearing patient.
— Remove the catheter before discharge whenever possible. Patients sent home with unnecessary catheters have high readmission and CAUTI rates.
— If catheter is necessary (chronic retention, palliation, wound healing), document indication, type, size, insertion date, and planned exchange/removal date.
— Provide written instructions: hand hygiene, perineal care, keeping bag below bladder, signs/symptoms of infection, when to call, when to go to ED.
— Define a clear stop date in the discharge summary — open-ended courses drive resistance and C. difficile.
— Avoid prophylactic antibiotics in chronically catheterized patients; not recommended and promotes MDR.
— No routine antibiotic at catheter exchange unless history of symptomatic infection with exchange.
— Intermittent catheterization (preferred for neurogenic bladder; lower CAUTI rates than indwelling).
— Suprapubic catheter for chronic indications — lower symptomatic UTI rate, better patient acceptance, fewer urethral complications.
— External catheters (condom or female external) when continence rather than retention is the issue.
— Behavioral/timed voiding programs and pelvic floor PT.
— Adequate hydration.
— Routine catheter and bag changes only as needed or per institutional protocol (no fixed interval shown superior).
— Address constipation (impacts bladder emptying).
— Treat only symptomatic episodes.
— Hospital-wide CAUTI bundle, nurse-driven removal protocols, EHR daily necessity prompts, audit-and-feedback dashboards, unit-level CAUTI rate reporting.
Step 3 management: A common Step 3 transition-of-care question: hospitalized patient improving from CAUTI with appropriate antibiotics — what is the next best step before discharge? Answer: remove the catheter, confirm spontaneous voiding (bladder scan post-void residual <100–200 mL), and complete oral antibiotics with PCP follow-up in 1–2 weeks. Sending home with the catheter "just in case" is wrong.
— Vitals q4–8h on floor; q1h if septic.
— Daily WBC, BMP (renal function on antibiotics); lactate trends if initially elevated.
— Reassess at 48–72 h: defervescence, hemodynamic stability, narrowing antibiotics per culture.
— Repeat blood cultures only if bacteremic or not improving.
— Document daily catheter necessity.
— Uncomplicated CAUTI managed as outpatient: phone or in-person check at 48–72 h; office visit in 1–2 weeks.
— Complicated CAUTI post-discharge: PCP visit within 1 week; urology referral if recurrent or anatomic concern.
— Pregnancy: monthly urine cultures through gestation after any UTI; test of cure 1–2 weeks after treatment.
— Pediatric febrile UTI: renal/bladder US; VCUG per AAP criteria.
— Not routinely indicated in non-pregnant adults after uncomplicated CAUTI resolution.
— Indicated in pregnancy, persistent symptoms, or post-procedure ASB treatment.
— Demonstrate sterile catheter care if going home with one.
— Hand hygiene before/after handling drainage bag.
— Keep drainage bag below bladder, off the floor.
— Adequate fluid intake (unless contraindicated by heart/renal disease).
— Recognize warning signs: fever, chills, flank pain, hematuria, no urine output, foul odor with systemic symptoms.
— Explicitly counsel: cloudy or smelly urine alone is not a reason to start antibiotics — call the office first.
— Glycemic control in diabetics (HbA1c target individualized).
— Treat constipation, optimize mobility, address atrophic vaginitis (topical estrogen reduces recurrent UTI in postmenopausal women).
Board pearl: Topical vaginal estrogen reduces recurrent UTI in postmenopausal women and is a high-yield, often-forgotten Step 3 answer choice for the older woman with recurrent symptomatic UTIs after catheter exposure — non-antibiotic, durable benefit, minimal systemic absorption.
— Although routine, document the indication and discuss risks (infection, urethral trauma, discomfort) with patient or surrogate when feasible. In emergencies (acute retention, unstable patient), implied consent applies.
— Patients with decision-making capacity may refuse catheterization even when clinically indicated; document the conversation, offer alternatives (intermittent catheterization, bladder scanning), and respect autonomy.
— Indwelling catheter for comfort in actively dying patients is an accepted indication, but routine catheterization for nursing convenience in hospice patients is not. Have explicit goals-of-care conversations; align with advance directives and POLST.
— CAUTI is a CMS hospital-acquired condition; institutions must report rates to NHSN. Misclassification or under-reporting to game metrics is fraud (False Claims Act exposure) — a Step 3 ethics distractor.
— Sentinel events (e.g., death from urosepsis attributable to a preventable CAUTI) may trigger root cause analysis and Joint Commission reporting.
— Discharging a patient with an indwelling catheter without clear indication, removal plan, or trained caregiver is a documented driver of readmission. The discharge summary must list catheter details, planned removal date, and follow-up clinician responsible.
— Medication reconciliation must include antibiotic stop date — open-ended prescriptions are a stewardship and patient-safety failure.
— Treating ASB exposes patients to C. difficile, allergic reactions, AKI, and MDR colonization without benefit. Stewardship programs are a Joint Commission requirement.
— Long-term care residents and patients with cognitive impairment are disproportionately subjected to unnecessary catheterization and ASB treatment — a health-equity and quality issue.
— PDSA cycles, run charts, control charts, Pareto analysis of catheter-day drivers; just-culture framework when CAUTI events occur — focus on system fixes, not individual blame.
Step 3 management: When a question asks about the most effective intervention to reduce CAUTI rates institutionally, the answer is almost always a systems intervention (nurse-driven removal protocol, EHR daily necessity prompt, audit-feedback) rather than a clinical intervention (antimicrobial-coated catheters, prophylactic antibiotics). Choose the system fix.
CCS pearl: When in doubt on the CCS exam, "discontinue Foley catheter" is often a high-value order that improves both clinical outcome and patient-safety scoring — order it on day 1 unless an explicit indication is met.
— "78-year-old nursing home resident with an indwelling catheter for 3 weeks is sent to the ED for cloudy, malodorous urine. Afebrile, normal vitals, no suprapubic or flank tenderness. UA: pyuria, positive nitrites. Culture pending. Next best step?"
— Answer: Reassess catheter necessity, remove if possible, do not start antibiotics, do not send culture. Treating ASB is wrong.
— "A hospital wants to reduce CAUTI rates. Which intervention is most effective?"
— Answer: Nurse-driven catheter removal protocol with daily necessity assessment. Not antimicrobial catheters, not prophylactic antibiotics, not bladder irrigation.
— "Hospital day 5, Foley × 4 days, new fever 39°C, BP 88/50, lactate 3.5. Next step?"
— Answer: Blood cultures × 2, remove/exchange catheter and culture urine from new catheter, broad-spectrum antibiotics (piperacillin-tazobactam ± vancomycin) within 1 hour, 30 mL/kg crystalloid, ICU.
— "Pyelonephritis on ceftriaxone × 72 h, still febrile. Next step?"
— Answer: CT abdomen/pelvis with contrast to evaluate for abscess or obstruction; broaden antibiotics; urology consult.
— "26-year-old at 14 weeks GA, asymptomatic, routine prenatal urine culture grows E. coli 10⁵ CFU/mL."
— Answer: Treat with cephalexin or amoxicillin-clavulanate × 5–7 days; test of cure; monthly cultures.
— "Hospital administrator suggests reclassifying CAUTI cases to reduce reported rates."
— Answer: This is fraud/unethical; refuse and pursue legitimate quality improvement.
— "Patient improving from CAUTI, voiding spontaneously after catheter removal, post-void residual 80 mL."
— Answer: Complete oral antibiotics, no catheter at discharge, PCP follow-up 1–2 weeks.
— Answer: Topical vaginal estrogen.
Key distinction: Pyuria + bacteriuria without urinary symptoms = ASB. Add fever or localizing GU symptoms = CAUTI. The test rewards withholding antibiotics in the first scenario and acting decisively in the second.
The CAUTI prevention bundle is fundamentally a discipline of not catheterizing when avoidable and removing promptly when no longer needed, supported by aseptic insertion, closed drainage, daily necessity review, and rigorous antimicrobial stewardship that refuses to treat asymptomatic bacteriuria outside pregnancy and pre-urologic procedure.
— Avoid and remove: Apply HOUDINI criteria daily; nurse-driven removal protocols are the single most effective systems intervention.
— Diagnose by symptoms, not by urine: Pyuria and bacteriuria are universal in catheterized patients; treat only when fever, suprapubic/CVA tenderness, hemodynamic change, or post-removal urinary symptoms localize the source. Always culture from a freshly placed catheter.
— Treat appropriately and stop: Ceftriaxone for moderate disease; piperacillin-tazobactam or cefepime ± vancomycin for sepsis or healthcare exposure; de-escalate by 48–72 h; total 7 days for prompt responders, 10–14 for complicated. Replace the catheter during treatment if in place >2 weeks. Image non-responders for abscess or obstruction; emergent decompression for obstructed infected kidney.
— Special populations: Treat ASB only in pregnancy and pre-urologic procedure. Use pregnancy-safe agents (cephalexin, amoxicillin-clavulanate, ceftriaxone). Renally dose cefepime to avoid neurotoxicity. Offer topical vaginal estrogen for recurrent UTI in postmenopausal women.
— Systems and ethics: CAUTI is a CMS hospital-acquired condition with public reporting and payment penalties; the right answers on Step 3 emphasize system-level fixes (PDSA, audit-feedback, EHR prompts), antimicrobial stewardship, and transition-of-care safety with explicit antibiotic stop dates and removal plans at discharge.
Board pearl: When the stem offers any of "send urine culture," "start antibiotics for cloudy urine," or "insert Foley for convenience" — these are almost always wrong. The right move is remove the catheter, reassess symptoms, and protect the patient from unnecessary antibiotics.